Similarly, the significance of PTEN expression as a marker of favourable outcome in combined modalities comprising irradiation has been reported for many other cancers, including astrocytomas [41], cervical [4], [42] and breast cancer [20], prostate [7], [8] and colorectal cancer [43]. The gene discussed is PTEN; the disease is breast cancer.